Insider Stock Trading History of Myszkowski Kenneth Allen


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Myszkowski Kenneth Allen since year 2005. The trader's CIK number is 1486672. At the time of this reporting, Myszkowski Kenneth Allen is the Chief Financial Officer of Arrowhead Pharmaceuticals, Inc. . (stock ticker symbol ARWR). See this page for all insider trading activities at Arrowhead Pharmaceuticals, Inc. .


Stock purchases, sales, and option exercises reported by insider Myszkowski Kenneth Allen since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-06-19 ARWR Arrowhead Pharmaceuticals, Inc. Option Ex 20,000 2.01 40,199
2018-06-19 ARWR Arrowhead Pharmaceuticals, Inc. Sale 20,000 14.01 280,200
2018-05-30 ARWR Arrowhead Pharmaceuticals, Inc. Option Ex 1,400 2.01 2,813
2018-05-31 ARWR Arrowhead Pharmaceuticals, Inc. Option Ex 12,600 2.01 25,325
2018-05-30 ARWR Arrowhead Pharmaceuticals, Inc. Sale 1,400 11.00 15,400
2018-05-31 ARWR Arrowhead Pharmaceuticals, Inc. Sale 12,600 11.00 138,600
2018-03-27 ARWR Arrowhead Pharmaceuticals, Inc. Option Ex 20,000 2.01 40,199
2018-03-27 ARWR Arrowhead Pharmaceuticals, Inc. Sale 20,000 8.00 160,000
2016-08-23 ARWR Arrowhead Pharmaceuticals, Inc. Sale 6,900 8.00 55,200
2016-08-22 ARWR Arrowhead Pharmaceuticals, Inc. Option Ex 13,100 2.01 26,330
2016-08-23 ARWR Arrowhead Pharmaceuticals, Inc. Option Ex 6,900 2.01 13,868
2016-08-22 ARWR Arrowhead Pharmaceuticals, Inc. Sale 13,100 8.00 104,800
2015-12-30 ARWR Arrowhead Pharmaceuticals, Inc. Sale 23,347 6.13 143,117
2014-08-15 ARWR Arrowhead Pharmaceuticals, Inc. Option Ex 40,000 6.09 243,800
2014-08-15 ARWR Arrowhead Pharmaceuticals, Inc. Sale 40,000 14.02 560,880
2014-02-12 ARWR Arrowhead Pharmaceuticals, Inc. Sale 16,000 18.77 300,288
2014-02-12 ARWR Arrowhead Pharmaceuticals, Inc. Option Ex 16,000 2.01 32,159
2010-08-27 ARWR Arrowhead Pharmaceuticals, Inc. Buy 15,000 .89 13,350

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Myszkowski Kenneth Allen (Chief Financial Officer of Arrowhead Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.